pills-384846_960_720-300x200-4567758If Governor Cuomo succeeds in imposing a surcharge on prescription opioids, state government would largely be taxing itself.

This is because the state’s Medicaid health plan for the low-income and disabled covers fully one-third of the state’s population—and therefore buys roughly one-third of the opioids. Plus, New York might not be able to split the cost with the federal government, as it usually does, which would double the bottom-line impact on state finances.

Consider the example of oxycodone, a popular opioid pain reliever. In the first six months of 2017, New York’s Medicaid program paid for 22.8 million oxycodone pills, federal records show. Assuming those pills were 15 milligrams each (one of the smaller dosages), that equates to 513 “morphine milligram equivalents,” or MMEs.

Thus Cuomo’s proposed tax of 2 cents per MME would amount to about $10.3 million—for half a year of a single opioid.

Normally, Washington provides matching aid equal to about 50 percent of New York’s Medicaid costs. But the feds might well refuse to reimburse this tax, as explained in a memorandum of opposition from the drug manufacturers’ lobby, PhRMA:

In calculating the federal share of assistance, Medicaid generally deducts revenues from health-care related taxes imposed by the state or local government unless such taxes are broad and uniform across an entire ‘class’ of items or services and meet certain other requirements. In this case, the tax is applied to a small subset of a class, the first sale of an opioid medication in the State. Absent a special approval from CMS [the Centers for Medicare & Medicaid Services], revenue from the first sale tax could therefore likely be offset by reductions in how much the federal government pays New York for Medicaid assistance.

The Cuomo administration has argued that the tax will be paid by organizations higher up in the chain of distribution, such as wholesalers and distributors, rather than end buyers. His proposed legislation says the opioid tax should be imposed on the first sale to a New York entity, and “shall not be added as a separate charge or line item on any invoice given to the customers or otherwise passed down to the customer.”

But his budget briefing book says, “This surcharge is expected to provide a financial disincentive for the use of these drugs”—which only makes sense if the cost is passed along to buyers.

Realistically, there is no way for the state to prevent the entities who pay the tax from building it into the prices they charge. That means the cost ultimately will fall not just those who overuse or abuse opioids, but also on those who take them legitimately.

Of the $125 million in projected revenue, Medicaid could expect to pay about one-third, or $42 million. The rest would fall on ordinary consumers. Among the targets would be terminally ill patients in hospice care and addicts in rehab using buprenorphine, an opioid-based medication, to help kick the habit.

Another question for lawmakers to consider is where the money would go. The governor proposes to put the revenue in a dedicated “Opioid Prevention, Treatment and Recovery Fund.” Yet his budget does not increase spending on drug treatment by $125 million, meaning the tax would mostly replace existing treatment funds rather than supplementing them.

In effect, the state would be taxing opioid buyers—including, most prominently, itself—to balance the budget.

About the Author

Bill Hammond

As the Empire Center’s senior fellow for health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

Minimum wage for home care aides is likely to mean bigger raises for downstate than upstate

The newly enacted wage hike for home care aides is likely to increase workers' pay more than three times as much in the New York City area as in other parts of the state, according to a review of labor data. Read More

The flawed arguments behind ‘Fair Pay for Home Care’

As they contemplate a major increase in Medicaid spending on home care for the elderly and disabled, state legislators are relying on information that's outdated, incomplete or inaccurate – and neglecting to think through the predictable consequences. Read More

The debate over Medicaid home-care funding needs a reality check

The push in Albany to boost wages for home health aides is seemingly disconnected from the larger realities of the state’s long-term care system. As they , officials in the home care industry are warning that the state faces an of in-home caregivers Read More

Answers needed on Governor Hochul’s health-care budget

The health-care agenda laid out by Governor Hochul in her budget proposal this week leaves a lot of questions unanswered. Here are a few of them. Read More

Putting Governor Hochul’s $10 billion health-care ‘investment’ in context

In her State of the State address this week, Governor Hochul prominently called for a $10 billion "multi-year investment" in the state's health care system, including $4 billion earmarked for wages and bonuses, with a goal Read More

Hochul faces a test on health insurance costs

With judicious use of her veto pen this month, Governor Hochul could draw a line against spiraling health expenses for consumers and taxpayers. Several health insurance-related bill Read More

The Health Department takes a big step toward COVID transparency

The state Health Department released a flurry of 20 COVID-related data sets this week, taking its biggest step yet toward full transparency about the state's pandemic response. Read More

Hochul’s Emergency Order Imposes Insurer Restrictions Sought by Hospital Group

Buried in Governor Hochul's emergency order on health-care staffing is a temporary bar against insurance companies challenging claims submitted by hospitals–and an influential hospital association is taking credit. Read More

Subscribe

Sign up to receive updates about Empire Center research, news and events in your email.

CONTACT INFORMATION

Empire Center for Public Policy
30 South Pearl St.
Suite 1210
Albany, NY 12207

Phone: 518-434-3100

General Inquiries: Info@EmpireCenter.org

Press Inquiries: Press@EmpireCenter.org

About

The Empire Center is an independent, non-partisan, non-profit think tank located in Albany, New York. Our mission is to make New York a better place to live and work by promoting public policy reforms grounded in free-market principles, personal responsibility, and the ideals of effective and accountable government.

Empire Center Logo Enjoying our work? Sign up for email alerts on our latest news and research.
Together, we can make New York a better place to live and work!